Published in Biochem Soc Trans on April 01, 2007
Choline kinase inhibition in rheumatoid arthritis. Ann Rheum Dis (2014) 2.17
Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes. Arthritis Rheumatol (2016) 1.50
Polyamines and suicide risk. Mol Psychiatry (2013) 0.75
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet (1995) 5.58
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet (1998) 4.96
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet (1996) 2.68
Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int (2001) 2.19
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93
Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin Cancer Res (2000) 1.91
Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child (1992) 1.86
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain (2000) 1.75
Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol (1999) 1.72
Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat (2000) 1.72
Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int (2007) 1.70
Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet (1994) 1.69
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int (2006) 1.60
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum (1998) 1.59
Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57
Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood (1996) 1.51
The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet (1999) 1.48
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet (1999) 1.48
Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr (1993) 1.47
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47
Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem Biophys Res Commun (2000) 1.46
Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol (2002) 1.42
Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest (1996) 1.42
Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet (2000) 1.35
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med (2012) 1.30
Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review. Eur J Pediatr (2009) 1.19
Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain (1999) 1.17
Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res (1998) 1.17
Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med (Berl) (1996) 1.17
A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis (1996) 1.16
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem (2003) 1.09
cDNA of eight nuclear encoded subunits of NADH:ubiquinone oxidoreductase: human complex I cDNA characterization completed. Biochem Biophys Res Commun (1998) 1.08
Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. J Biol Chem (2000) 1.08
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int (2007) 1.05
6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol (1993) 1.03
Molecular cloning, tissue distribution, and chromosomal mapping of the human epithelial Ca2+ channel (ECAC1). Genomics (2000) 1.03
Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency. Clin Chim Acta (1984) 1.03
Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol (2001) 1.03
DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome. J Med Genet (2004) 1.02
Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem (1998) 1.02
Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders. J Bioenerg Biomembr (1998) 1.02
Genetic variation in ICF syndrome: evidence for genetic heterogeneity. Hum Mutat (2000) 1.01
Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. Eur J Cancer (1997) 1.01
Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. Kidney Int (2007) 1.00
SURFEIT-1 gene analysis and two-dimensional blue native gel electrophoresis in cytochrome c oxidase deficiency. Biochem Biophys Res Commun (1999) 0.99
Two novel missense mutations in the cystathionine beta-synthase gene in homocystinuric patients. Hum Genet (1995) 0.97
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol (2001) 0.97
Polyamines and prostatic cancer. Biochem Soc Trans (2003) 0.95
Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem (1998) 0.95
A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. J Med Genet (2007) 0.95
Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Hum Genet (1996) 0.95
Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis (2002) 0.94
Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation (2000) 0.94
Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am J Hum Genet (1998) 0.94
Utilisation of medical technology assessment in health policy. Health Policy (1997) 0.92
Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages. Biochem Pharmacol (1988) 0.92
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J Clin Invest (1995) 0.92
Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol (1999) 0.91
Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol (2000) 0.90
Nuclear genes of human complex I of the mitochondrial electron transport chain: state of the art. Hum Mol Genet (1998) 0.90
Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption. Neuropediatrics (2005) 0.90
Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts. Biochem Pharmacol (1993) 0.89
Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release. Cell Calcium (2012) 0.89
Human mitochondrial complex I deficiency: investigating transcriptional responses by microarray. Neuropediatrics (2003) 0.88
Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol (2001) 0.88
Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatr Nephrol (1996) 0.88
Argininosuccinic aciduria: clinical and biochemical findings in three children with the late onset form, with special emphasis on cerebrospinal fluid findings of amino acids and pyrimidines. Neuropediatrics (1993) 0.88
Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet (1998) 0.88
Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts. Biochem J (1994) 0.87
Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine. Biochem Pharmacol (1995) 0.87
A common 844INS68 insertion variant in the cystathionine beta-synthase gene. Biochem Mol Med (1997) 0.87
Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration. Biochim Biophys Acta (2012) 0.87
Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane. Nephrol Dial Transplant (1999) 0.87
Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer (1995) 0.87
Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations. Hum Mutat (2000) 0.87
Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clin Chim Acta (1989) 0.86
Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium. Exp Nephrol (2001) 0.86
Infantile Progressive Hepatoencephalomyopathy with Combined OXPHOS Deficiency due to Mutations in the Mitochondrial Translation Elongation Factor Gene GFM1. JIMD Rep (2011) 0.86
A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). J Inherit Metab Dis (1999) 0.86
2,8-Dihydroxyadenine stone formation in a renal transplant recipient due to adenine phosphoribosyltransferase deficiency. J Urol (1996) 0.86
Homocysteine metabolism in endothelial cells of a patient homozygous for cystathionine beta-synthase (CS) deficiency. Thromb Haemost (1997) 0.85
Importance of mitochondrial transmembrane processes in human mitochondriopathies. J Bioenerg Biomembr (1996) 0.85
2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. Mol Genet Metab (2001) 0.85
Deficiency of the voltage-dependent anion channel: a novel cause of mitochondriopathy. Pediatr Res (1996) 0.85
Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia (1995) 0.85
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia. Hum Genet (1998) 0.85
Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Clin Chem (1999) 0.84
Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts. Biochem Pharmacol (1986) 0.84
Dihydropyrimidinase deficiency, a progressive neurological disorder? Neuropediatrics (1997) 0.84
Glomerular extracellular matrix and growth factors in diffuse mesangial sclerosis. Pediatr Nephrol (2001) 0.84